Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed aggressive non-Hodgkin’s lymphoma

Published: June 8, 2009
Abstract Views: 156
PDF: 141
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We conducted a multicenter phase II trial for salvage treatment of relapsed lymphomas; 170 pts received allogeneic SCT from HLA identical sibling donors at 22 italian centers. RIC regimen included thiotepa, fludarabine and cyclophosphamide. GVHD prophylaxis consisted of cyclosporine A and short-course methotrexate.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Corradini, P., Dodero, A., Bregni, M., Olivieri, A., Valagussa, P., & Farina, L. (2009). Reduced-intensity allogeneic stem cell transplantation is an effective salvage treatment for relapsed aggressive non-Hodgkin’s lymphoma. Hematology Meeting Reports (formerly Haematologica Reports), 2(7). https://doi.org/10.4081/hmr.v2i7.423